Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7461 p61-67
21 July 2007

This section
Reprint   Photocopy

PDF 170K, Acrobat Reader

News summary, including R&D

DIARY   Branch meetings   Future Events

Pages: 61   62   63   64   65   66  R&D 67

61 Regulatory change team revealed Membership of the oversight group that will work with health ministers to establish the General Pharmaceutical Council and to advise on the formation of a professional leadership body was announced by the Department of Health last week. However, its composition has been criticised by some pharmacy organisations
PJ 2007;279:61
Full Text

61 Dawn Primarolo is named new minister in charge of pharmacy Dawn Primarolo, Minister of State for Public Health, is the new minister responsible for pharmacy at the Department of Health
PJ 2007;279:61
Full Text

61Regulation needs to be “reframed”, Keith Ridge tells the College of Pharmacy Practice Formation of a General Pharmaceutical Council should allow for time for rethinking the role of regulation, Keith Ridge, chief pharmaceutical officer for England, believes
PJ 2007;279:61
Full Text


62 Push for ETP roll-out in Scotland NHS boards in Scotland were told this week to check up on local implementation of electronic transmission of prescriptions (ETP), as part of a push by the Scottish Executive to keep the ePharmacy programme on track
PJ 2007;279:62
Full Text

62 NHS cancer planning system wins recognition A web-based oncology services planning system, being rolled out across UK cancer networks, has been selected by information technology magazine CIO as one of the world's top 100 IT initiatives for 2007
PJ 2007;279:62
Full Text

62 Aberdeen student invents handy dose reminder alarm Patients could be given an egg-shaped device to remind them when to take their medicines, if a prototype designed by a Robert Gordon University student comes to fruition
PJ 2007;279:62
Full Text

62 NPA issues EPS warning Pharmacists who are not prepared for the electronic prescription service (EPS) are running a significant business risk, the National Pharmacy Association has warned
PJ 2007;279:62
Full Text

62 Mobiles aid Boots diagnoses People are seeking advice from pharmacists about conditions they find embarrassing by using photographs of the problem taken with a mobile telephone or digital camera, according to Boots The Chemists
PJ 2007;279:62
Full Text


63 Company chemists reject emphasis in APPG report Pressure from the All-Party Pharmacy Group for the community pharmacy sector to focus on health, rather than retailing, has been rejected by the Company Chemists' Association
PJ 2007;279:63
Full Text

63 Alcohol gel supplies for patients suggested Hospital patients could be given personal supplies of alcohol-based hand cleanser to be offered to health professionals before they treat them as a way of tackling hospital-acquired infections
PJ 2007;279:63
Full Text

63 Pharmacy control of pseudoephedrine sales to be scrutinised The pharmacy profession will be scrutinised over the next few months to see if it can control the inappropriate use of pseudoephedrine purchased from its outlets, according to pharmacy organisations
PJ 2007;279:63
Full Text

63 Revised code of ethics The new Code of Ethics for Pharmacists and Pharmacy Technicians, which comes into effect on 1 August 2007, is distributed this week with The Journal
PJ 2007;279:63
Full Text

63 MUR numbers rise The number of medicines use reviews undertaken by pharmacists in England has risen from fewer than 147,000 in 2005–06 to over 557,000 in 2006–07, figures released last week by the Pharmaceutical Services Negotiating Committee show
PJ 2007;279:63
Full Text

63 NHS trust announces job cuts Scarborough and North East Yorkshire Healthcare NHS Trust has announced that the equivalent of 600 full-time posts — a third of its workforce — are to be made redundant
PJ 2007;279:63
Full Text


64 Greater emphasis on off-label prescribing needed Greater emphasis on dealing with off-label prescribing is needed in pharmacy undergraduate and postgraduate education, say the authors of a study published
PJ 2007;279:64
Full Text

64 Selenium supplements linked with diabetes Taking selenium supplements may increase the risk of developing type 2 diabetes, according to research published online
PJ 2007;279:64
Full Text

64 Doses of vitamin C do not protect against common cold Prophylatic use of vitamin C does not offer protection against the common cold in the general population but can reduce the duration of illness, a review suggests
PJ 2007;279:64
Full Text

64 UEA awards honorary degree to Sandy Florence as students graduate from first new pharmacy school for 30 years The first undergraduate cohort from the University of East Anglia's school of pharmacy received their degrees at a ceremony last week. They are the first to graduate from a new school of pharmacy for over 30 years
PJ 2007;279:64
Full Text

64 Bath celebrates its centenary More than 700 former students, members of staff and other guests took part in celebrations to mark 100 years of pharmacy research and education in Bath earlier this month
PJ 2007;279:64
Full Text


65 Reprimands for three companies Bayer, GlaxoSmithKline and Roche are to be publicly reprimanded in advertisements that will be taken out by the Prescription Medicines Code of Practice Authority
PJ 2007;279:65
Full Text

65 EU and US to widen co-operation Regulatory co-operation between the EU and the US is to be expanded to include confidential exchanges of information on paediatric medicines and orphan drugs
PJ 2007;279:65
Full Text

65 EU introduces fines for licensing breaches Pharmaceutical companies can now be fined up to 5 per cent of their EU turnover if they break the centralised European medicines licensing rules
PJ 2007;279:65
Full Text


66 SMC accepts four new medicines Rotigotine transdermal patches have been accepted for use by the NHS in Scotland following a resubmission by their manufacturer to the Scottish Medicines Consortium. The product is to be used as monotherapy to treat the signs and symptoms of early stage Parkinson's disease
PJ 2007;279:66
Full Text

66 Healthcare Commission report reveals diabetes service gaps Less than a sixth of primary care trusts in England received an overall score of “good” or “excellent” in the Healthcare Commission’s report on diabetes services, published this week
PJ 2007;279:66
Full Text

66 Saline nasal spray can relieve rhinosinusitis symptoms Spraying saline into the nostrils can relieve the symptoms associated with chronic rhinosinusitis but is not as effective as an intranasal steroid, a review of eight randomised trials has concluded
PJ 2007;279:66
Full Text

66 Paracetamol for ankle pain Paracetamol is as effective as naproxen in relieving ankle-sprain discomfort in children, say researchers, who compared the two drugs in 77 children, aged eight to 14 years
PJ 2007;279:66
Full Text

66 Anticoagulants and antiplatelets Adding an oral anticoagulant to antiplatelet therapy does not reduce the likelihood of patients with peripheral arterial disease experiencing a major cardiovascular complication and increases the chance of a life-threatening bleed occurring, data from a study published
PJ 2007;279:66
Full Text


R&D news

67 New rheumatoid arthritis treatments show promise Two investigational drugs for rheumatoid arthritis — tocilizumab and certolizumab pegol — have shown promise in Phase III studies, data from which were presented at the Annual European Congress of Rheumatology, held last month in Barcelona
PJ 2007;279:67
Full Text

67 New oral anticoagulants offer benefits for orthopaedic surgery patients, say researchers Two new oral anticoagulants offer improvements in terms of ease of administration for patients undergoing orthopaedic surgery and one my reduce the risk of venous thromboembolism, the results of Phase III trials suggest
PJ 2007;279:67
Full Text

67 Encouraging results for new NNRTI in resistant HIV patients Use of the non-nucleoside reverse transcriptase inhibitor (NNRTI) etravirine, for treatment-experienced patients with NNRTI resistance, achieves better virological suppression than placebo, according to the results of two trials published
PJ 2007;279:67
Full Text

67 Data suggest effective new drug for Crohn's disease Certolizumab pegol is an effective treatment for adults with Crohn's disease, two new studies indicate
PJ 2007;279:67
Full Text

Back to Top


©The Pharmaceutical Journal